Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5934)
All Articles published online
|
Feb 1, 2004 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qin XL, Wang ZR, Shi JS, Lu M, Wang L, He QR. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA. World J Gastroenterol 2004; 10(3): 427-432 [PMID: 14760772 DOI: 10.3748/wjg.v10.i3.427] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i3/427.htm |
| Number | Citing Articles |
| 1 |
Yuki Tanisaka, Masafumi Mizuide, Akashi Fujita, Tomoya Ogawa, Masahiro Suzuki, Hiromune Katsuda, Youichi Saito, Kazuya Miyaguchi, Tomoaki Tashima, Yumi Mashimo, Shomei Ryozawa. Diagnostic Process Using Endoscopy for Biliary Strictures: A Narrative Review. Journal of Clinical Medicine 2021; 10(5): 1048 doi: 10.3390/jcm10051048
|
| 2 |
Seung Tai Kim, Joon Oh Park, Jeeyun Lee, Kyu Taek Lee, Jong Kyun Lee, Seong‐Ho Choi, Jin‐Seok Heo, Young Suk Park, Won Ki Kang, Keunchil Park. A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer 2006; 106(6): 1339 doi: 10.1002/cncr.21741
|
| 3 |
Sven H. Loosen, Mihael Vucur, Christian Trautwein, Christoph Roderburg, Tom Luedde. Circulating Biomarkers for Cholangiocarcinoma. Digestive Diseases 2018; 36(4): 281 doi: 10.1159/000488342
|
| 4 |
Wanjin Chen, Shouwen Wang, Hongchuan Zhao, Guobin Wang, Rong Qin, Fan Huang, Wei Geng, Zimei Liu, Wei Wang, Ruolin Wu, Liujin Hou, Zhenghui Ye, Xinghua Zhang, Xiaoping Geng, Xiaojun Yu. High level of tumor marker CA19-9 returned to normal after cholecystectomy in calculous cholecystitis patients. Scandinavian Journal of Gastroenterology 2023; 58(6): 643 doi: 10.1080/00365521.2022.2163184
|
| 5 |
Mathew Vithayathil, Shahid A. Khan. Current epidemiology of cholangiocarcinoma in Western countries. Journal of Hepatology 2022; 77(6): 1690 doi: 10.1016/j.jhep.2022.07.022
|
| 6 |
Wei-Chun Tsai, Lien-Yu Hung, Teng-Yi Huang, Yen-Shen Shan, Shang-Cheng Hung, Gwo-Bin Lee. A microfluidic system for detection of cholangiocarcinoma cells by using heparan sulfate octasaccharides. 2017 IEEE 12th International Conference on Nano/Micro Engineered and Molecular Systems (NEMS) 2017; : 489 doi: 10.1109/NEMS.2017.8017070
|
| 7 |
Chris Verathamjamras, Churat Weeraphan, Daranee Chokchaichamnankit, Kamolwan Watcharatanyatip, Pantipa Subhasitanont, Penchatr Diskul-Na-Ayudthaya, Kanokwan Mingkwan, Virat Luevisadpaibul, Somchai Chutipongtanate, Voraratt Champattanachai, Jisnuson Svasti, Chantragan Srisomsap. Secretomic profiling of cells from hollow fiber bioreactor reveals PSMA3 as a potential cholangiocarcinoma biomarker. International Journal of Oncology 2017; 51(1): 269 doi: 10.3892/ijo.2017.4024
|
| 8 |
Felix Hahn, Lukas Müller, Florian Jungmann, Aline Mähringer-Kunz, Yasemin Tanyildizi, Christoph Düber, Peter R. Galle, Arndt Weinmann, Roman Kloeckner. Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging. Journal of Cancer Research and Clinical Oncology 2020; 146(7): 1883 doi: 10.1007/s00432-020-03200-2
|
| 9 |
Wen-Jing Wang, Wang-Hong Xu, Cha-Zhen Liu, Asif Rashid, Jia-Rong Cheng, Ping Liao, Heng Hu, Lisa W. Chu, Yu-Tang Gao, Kai Yu, Ann W. Hsing. Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry. Cancers 2010; 2(3): 1602 doi: 10.3390/cancers2031602
|
| 10 |
Atit Silsirivanit, Norie Araki, Chaisiri Wongkham, Chawalit Pairojkul, Yoshiki Narimatsu, Kazuhiko Kuwahara, Hisashi Narimatsu, Sopit Wongkham, Nobuo Sakaguchi. A novel serum carbohydrate marker on mucin 5AC. Cancer 2011; 117(15): 3393 doi: 10.1002/cncr.25912
|
| 11 |
Nichol S. Martinez, Arvind J. Trindade, Divyesh V. Sejpal. Determining the Indeterminate Biliary Stricture: Cholangioscopy and Beyond. Current Gastroenterology Reports 2020; 22(12) doi: 10.1007/s11894-020-00797-9
|
| 12 |
Deyao Zhang, Huilan Zeng, Yangxun Pan, Yumo Zhao, Xin Wang, Jinbin Chen, Juncheng Wang, Yaojun Zhang, Zhongguo Zhou, Li Xu, Minshan Chen, Dandan Hu. Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery. Journal of Personalized Medicine 2022; 12(12): 2041 doi: 10.3390/jpm12122041
|
| 13 |
Sven H. Loosen, Christoph Roderburg, Katja L. Kauertz, Alexander Koch, Mihael Vucur, Anne T. Schneider, Marcel Binnebösel, Tom F. Ulmer, Georg Lurje, Wenzel Schoening, Frank Tacke, Christian Trautwein, Thomas Longerich, Cornelis H. Dejong, Ulf P. Neumann, Tom Luedde. CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17175-7
|
| 14 |
Sebastian Blaj, David Dora, Zoltan Lohinai, Zoltan Herold, Attila Marcell Szasz, Jonas Herzberg, Roland Kodacsi, Saher Baransi, Hans Jürgen Schlitt, Matthias Hornung, Jens M. Werner, Przemyslaw Slowik, Miklos Acs, Pompiliu Piso. Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers. Cancers 2023; 15(4): 1326 doi: 10.3390/cancers15041326
|
| 15 |
Jae Hyun Lee, Dong-Kun Kim, Mi-Yeon Lee, Han-Sol Lim, Min-Jung Kwon, Yong-Taek Lee, Kyung Jae Yoon, Chul-Hyun Park. The Association of Carbohydrate Antigen (CA) 19-9 Levels and Low Skeletal Muscle Mass in Healthy Adults. Nutrients 2023; 15(15): 3394 doi: 10.3390/nu15153394
|
| 16 |
Yiannis Petros Dimopoulos, Emily R Winslow, Aiwu Ruth He, Metin Ozdemirli. Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report. World Journal of Clinical Oncology 2021; 12(4): 262-271 doi: 10.5306/wjco.v12.i4.262
|
| 17 |
Rungsun Rerknimitr, Phonthep Angsuwatcharakon, Thawee Ratanachu‐ek, Christopher J L Khor, Ryan Ponnudurai, Jong Ho Moon, Dong Wan Seo, Linda Pantongrag‐Brown, Apichat Sangchan, Pises Pisespongsa, Thawatchai Akaraviputh, Nageshwar D Reddy, Amit Maydeo, Takao Itoi, Nonthalee Pausawasdi, Sundeep Punamiya, Siriboon Attasaranya, Benedict Devereaux, Mohan Ramchandani, Khean‐Lee Goh. Asia–Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. Journal of Gastroenterology and Hepatology 2013; 28(4): 593 doi: 10.1111/jgh.12128
|
| 18 |
Remco Kersten, David C. Trampert, Toni Herta, Lowiek M. Hubers, Lucas J. Maillette de Buy Wenniger, Joanne Verheij, Stan F.J. van de Graaf, Ulrich Beuers. IgG4-related cholangitis – a mimicker of fibrosing and malignant cholangiopathies. Journal of Hepatology 2023; 79(6): 1502 doi: 10.1016/j.jhep.2023.08.005
|
| 19 |
Hong-Wei Huang, Hao Wang, Chao Leng, Bin Mei. Formation and rupture of liver hematomas caused by intrahepatic gallbladder perforation: A case report and review of literature. World Journal of Gastrointestinal Surgery 2024; 16(10): 3301-3311 doi: 10.4240/wjgs.v16.i10.3301
|
| 20 |
Rocio I. R. Macias, Miroslaw Kornek, Pedro M. Rodrigues, Nuno A. Paiva, Rui E. Castro, Sabine Urban, Stephen P. Pereira, Massimiliano Cadamuro, Christian Rupp, Sven H. Loosen, Tom Luedde, Jesus M. Banales. Diagnostic and prognostic biomarkers in cholangiocarcinoma. Liver International 2019; 39(S1): 108 doi: 10.1111/liv.14090
|
| 21 |
Chisaki Ikeda, Hiroaki Haga, Naohiko Makino, Tatsutoshi Inuzuka, Ayako Kurimoto, Toshiki Ueda, Akiko Matsuda, Yasuharu Kakizaki, Tetsuya Ishizawa, Toshikazu Kobayashi, Shinpei Sugahara, Michihiko Tsunoda, Kensei Suda, Yoshiyuki Ueno. Utility of Claudin-3 in extracellular vesicles from human bile as biomarkers of cholangiocarcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81023-y
|
| 22 |
Amaar Ghazale, Suresh T. Chari, Lizhi Zhang, Thomas C. Smyrk, Naoki Takahashi, Michael J. Levy, Mark D. Topazian, Jonathan E. Clain, Randall K. Pearson, Bret T. Petersen, Santhi Swaroop Vege, Keith Lindor, Michael B. Farnell. Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy. Gastroenterology 2008; 134(3): 706 doi: 10.1053/j.gastro.2007.12.009
|
| 23 |
Mrinalini Meesala, Muhammad Raza, Avneesh Chhabra, Nilay Mehta, Diwakar Jain. Hepatobiliary abnormalities on nuclear perfusion imaging. Journal of Nuclear Cardiology 2006; 13(2): 297 doi: 10.1007/BF02971254
|
| 24 |
Leva Gorji, Eliza W. Beal. Surgical Treatment of Distal Cholangiocarcinoma. Current Oncology 2022; 29(9): 6674 doi: 10.3390/curroncol29090524
|
| 25 |
Seungho Lee, Hongbeom Kim, Heeju Sohn, Mirang Lee, Hyesol Jung, Youngjae Jo, Youngmin Han, Wooil Kwon, Jin-Young Jang. The Optimal Cutoff Value of Tumor Markers for Prognosis Prediction in Ampullary Cancer. Cancers 2023; 15(8): 2281 doi: 10.3390/cancers15082281
|
| 26 |
Nadine Soliman, Ashton A. Connor, Sudha Kodali, Rafik Mark Ghobrial. Liver Transplantation for Cholangiocarcinoma. Digestive Disease Interventions 2024; doi: 10.1055/s-0044-1787171
|
| 27 |
Takashi Kobayashi, Masanori Teruya, Seiichirou Shimizu. Immunoglobulin G4-associated cholangitis. Surgery 2010; 147(5): 748 doi: 10.1016/j.surg.2009.01.001
|
| 28 |
Adrianne Tsen, Mary Barbara, Laura Rosenkranz. Dilemma of elevated CA 19-9 in biliary pathology. Pancreatology 2018; 18(8): 862 doi: 10.1016/j.pan.2018.09.004
|
| 29 |
Kitti Intuyod, Napat Armartmuntree, Apinya Jusakul, Chadamas Sakonsinsiri, Raynoo Thanan, Somchai Pinlaor. Current omics-based biomarkers for cholangiocarcinoma. Expert Review of Molecular Diagnostics 2019; 19(11): 997 doi: 10.1080/14737159.2019.1673162
|
| 30 |
James Neuberger. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 1737 doi: 10.1016/B978-0-323-34062-5.00112-6
|
| 31 |
Amit Singal, Theodore H Welling, Jorge A Marrero. Role of liver transplantation in the treatment of cholangiocarcinoma. Expert Review of Anticancer Therapy 2009; 9(4): 491 doi: 10.1586/era.09.5
|
| 32 |
Yu‑Xue Gao, Tong‑Wang Yang, Ji‑Ming Yin, Peng‑Xiang Yang, Bu‑Xin Kou, Meng‑Yin Chai, Xiao‑Ni Liu, De‑Xi Chen. Progress and prospects of biomarkers in�primary liver cancer (Review). International Journal of Oncology 2020; doi: 10.3892/ijo.2020.5035
|
| 33 |
Qing Wang, Shaoqiong Lu, Ying Chen, Hua He, Weihui Lu, Kanru Lin. Analysis of transcriptome in the relationship between expression of PRC1 protein and prognosis of patients with cholangiocarcinoma. Journal of International Medical Research 2021; 49(3) doi: 10.1177/0300060521989200
|
| 34 |
Sho Yasuta, Motokazu Sugimoto, Masashi Kudo, Shin Kobayashi, Shinichiro Takahashi, Masaru Konishi, Naoto Gotohda. Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10453-2
|
| 35 |
Sikhakolli Sravan Kumar, Omm Prakash Sahoo, Gagan Mundada, Suresh Aala, Dorababu Sudarsa, Om Jee Pandey, Sunil Chinnadurai, Osamu Matoba, Inbarasan Muniraj, Anuj Deshpande. Deep learning-based hyperspectral microscopic imaging for cholangiocarcinoma detection and classification. Optics Continuum 2024; 3(8): 1311 doi: 10.1364/OPTCON.527576
|
| 36 |
Bastian Domajnko, Steven A. Ahrendt. Indications for non‐transplant surgery in primary sclerosing cholangitis. HPB 2005; 7(4): 292 doi: 10.1080/13651820500273392
|
| 37 |
Yu-Ling Chen, Chien-Hung Chen, Rey-Heng Hu, Ming-Chih Ho, Yung-Ming Jeng, Johann Hofmann, David Morris. Elevated Preoperative Serum CA19‐9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection. The Scientific World Journal 2013; 2013(1) doi: 10.1155/2013/380797
|
| 38 |
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget 2017; 8(8): 14192 doi: 10.18632/oncotarget.13929
|
| 39 |
Hoon Hur, Il-Young Park, Gi-Young Sung, Do-Sang Lee, Wook Kim, Jong-Man Won. Intrahepatic Cholangiocarcinoma Associated with Intrahepatic Duct Stones. Asian Journal of Surgery 2009; 32(1): 7 doi: 10.1016/S1015-9584(09)60002-6
|
| 40 |
J. NEUBERGER. Surgery of the Liver, Biliary Tract and Pancreas. 2007; : 1717 doi: 10.1016/B978-1-4160-3256-4.50123-X
|
| 41 |
Yuanfu Qiu, Jian He, Xinliang Chen, Pinbo Huang, Kaishun Hu, Haiyan Yan. The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma. Clinica Chimica Acta 2018; 480: 186 doi: 10.1016/j.cca.2018.02.008
|
| 42 |
Yueting Han, Haiyang Zhang, Zhengyang Zhou, Rui Liu, Dongying Liu, Ming Bai, Qian Fan, Jialu Li, Kegan Zhu, Hongli Li, Tao Ning, Guoguang Ying, Yi Ba. Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer. International Journal of General Medicine 2021; : 1185 doi: 10.2147/IJGM.S297371
|
| 43 |
Thomas B. Karasic, Jennifer R. Eads, Lipika Goyal. Precision Medicine and Immunotherapy Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials. JCO Precision Oncology 2023; (7) doi: 10.1200/PO.22.00573
|
| 44 |
Toru Yamada, Yoshitsugu Nakanishi, Keisuke Okamura, Takahiro Tsuchikawa, Toru Nakamura, Takehiro Noji, Toshimichi Asano, Kimitaka Tanaka, Yo Kurashima, Yuma Ebihara, Soichi Murakami, Toshiaki Shichinohe, Tomoko Mitsuhashi, Satoshi Hirano. Impact of serum carbohydrate antigen 19‐9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma. Journal of Gastroenterology and Hepatology 2018; 33(9): 1626 doi: 10.1111/jgh.14124
|
| 45 |
Mazen A. Juratli, Benjamin Struecker, Shadi Katou, M. Haluk Morguel, Andreas Pascher. Einfluss der Molekularpathologie auf die onkologische Chirurgie von Leber- und Gallengangstumoren. Der Chirurg 2021; 92(11): 1003 doi: 10.1007/s00104-021-01495-6
|
| 46 |
Marian A. Taulescu, Pompei F. Bolfă, Rareş Buiga, Adrian F. Gal, Bogdan Sevastre, Iancu Morar, Cornel Cătoi. Metastatic cholangiocarcinoma in a llama (Lama glama). Journal of Veterinary Diagnostic Investigation 2012; 24(5): 986 doi: 10.1177/1040638712452110
|
| 47 |
Shoji Kubo, Shigekazu Takemura, Shogo Tanaka, Takayoshi Nishioka, Masahiko Kinoshita, Genya Hamano, Tokuji Ito, Takatsugu Yamamoto, Makoto Abue, Masaru Aoki, Kei Nakagawa, Susumu Hijioka, Atsushi Miyamoto, Yukio Osaki, Ginji Endo, Shinji Kumagai. Screening and surveillance for occupational cholangiocarcinoma in workers exposed to organic solvents. Surgery Today 2016; 46(6): 705 doi: 10.1007/s00595-015-1229-9
|
| 48 |
T. Maebayashi, N. Ishibashi, T. Aizawa, M. Sakaguchi, M. Okada. Stereotactic radiotherapy for hepatocellular carcinoma induced by hepatitis C and the relationships of changes in carbohydrate antigen 19-9 with AFP and PIVKA-II. Cancer/Radiothérapie 2021; 25(3): 242 doi: 10.1016/j.canrad.2020.09.005
|
| 49 |
Wipaporn JARUJAREET, Kensuke TAIRA, Hong Kean OOI. Dynamics of liver enzymes in rabbits experimentally infected with <i>Fasciola</i> sp. (Intermediate form from Japan). Journal of Veterinary Medical Science 2018; 80(1): 36 doi: 10.1292/jvms.17-0315
|
| 50 |
Ali Nada, Alzhraa Alkhatib, Fady Abdelmalik, Mona El-Abd, Naglaa S. Elabd, Hossam El-Din Abdel-Latif. Bile level of cytokeratin 7 as a diagnostic marker for cholangiocarcinoma: a case-control study in Egyptian patients. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00353-4
|
| 51 |
Maria E. Lozada, Roongruedee Chaiteerakij, Lewis R. Roberts. Screening for Hepatocellular Carcinoma and Cholangiocarcinoma: Can Biomarkers Replace Imaging?. Current Hepatology Reports 2015; 14(2): 128 doi: 10.1007/s11901-015-0261-y
|
| 52 |
Wei-Feng Shen, Wei Zhong, Feng Xu, Tong Kan, Li Geng, Feng Xie, Cheng-Jun Sui, Jia-Mei Yang. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World Journal of Gastroenterology 2009; 15(47): 5976-5982 doi: 10.3748/wjg.15.5976
|
| 53 |
Sundeep Singh Saluja, Raju Sharma, Sujoy Pal, Peush Sahni, Tushar Kanti Chattopadhyay. Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: A prospective study. HPB 2007; 9(5): 373 doi: 10.1080/13651820701504207
|
| 54 |
Tavan Janvilisri, Kawin Leelawat, Sittiruk Roytrakul, Atchara Paemanee, Rutaiwan Tohtong. Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/105358
|
| 55 |
Tomoya Kishimoto, Hidetoshi Eguchi, Hiroaki Nagano, Shogo Kobayashi, Hirofumi Akita, Naoki Hama, Hiroshi Wada, Koichi Kawamoto, Akira Tomokuni, Yoshito Tomimaru, Koji Umeshita, Yuichiro Doki, Masaki Mori. Plasma miR‐21 is a novel diagnostic biomarker for biliary tract cancer. Cancer Science 2013; 104(12): 1626 doi: 10.1111/cas.12300
|
| 56 |
Sukanya Luang, Masahiko Minamiya, Nobuo Sakaguchi. Diagnosis and Management of Cholangiocarcinoma. 2021; : 163 doi: 10.1007/978-3-030-70936-5_6
|
| 57 |
Elisa Catanzaro, Enrico Gringeri, Patrizia Burra, Martina Gambato. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies. Cancers 2023; 15(20): 4947 doi: 10.3390/cancers15204947
|
| 58 |
Komila Rasuleva, Santhalingam Elamurugan, Aaron Bauer, Mdrakibhasan Khan, Qian Wen, Zhaofan Li, Preston Steen, Ang Guo, Wenjie Xia, Sijo Mathew, Rick Jansen, Dali Sun. β-Sheet Richness of the Circulating Tumor-Derived Extracellular Vesicles for Noninvasive Pancreatic Cancer Screening. ACS Sensors 2021; 6(12): 4489 doi: 10.1021/acssensors.1c02022
|
| 59 |
Suparat Cotchim, Supatinee Kongkaew, Panote Thavarungkul, Proespichaya Kanatharana, Warakorn Limbut. A dual-electrode label-free immunosensor based on in situ prepared Au–MoO3-Chi/porous graphene nanoparticles for point-of-care detection of cholangiocarcinoma. Talanta 2024; 272: 125755 doi: 10.1016/j.talanta.2024.125755
|
| 60 |
Vor Luvira, Kasama Nilprapha, Vajarabhongsa Bhudhisawasdi, Ake Pugkhem, Nittaya Chamadol, Supot Kamsa-ard. Cholangiocarcinoma Patient Outcome in Northeastern Thailand: Single-Center Prospective Study. Asian Pacific Journal of Cancer Prevention 2016; 17(1): 401 doi: 10.7314/APJCP.2016.17.1.401
|
| 61 |
Thomas Gerhardt, Sabine Milz, Michael Schepke, Georg Feldmann, Martin Wolff, Tilman Sauerbruch, Franz Ludwig Dumoulin. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World Journal of Gastroenterology 2006; 12(34): 5495-5500 doi: 10.3748/wjg.v12.i34.5495
|
| 62 |
Kaige YANG, Weiwei WANG, Yan WANG, Chao YAN. Proteomic analysis of serum and serum exosomes, and their application in intrahepatic cholangiocarcinoma. Chinese Journal of Chromatography 2021; 39(11): 1191 doi: 10.3724/SP.J.1123.2021.04009
|
| 63 |
Sandra Strainiene, Kotryna Sedleckaite, Juozas Jarasunas, Ilona Savlan, Juozas Stanaitis, Ieva Stundiene, Tomas Strainys, Valentina Liakina, Jonas Valantinas. Complicated course of biliary inflammatory myofibroblastic tumor mimicking hilar cholangiocarcinoma: A case report and literature review. World Journal of Clinical Cases 2021; 9(21): 6155-6169 doi: 10.12998/wjcc.v9.i21.6155
|
| 64 |
Chien Peter Chen, Daphne Haas-Kogan. Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics. Expert Review of Molecular Diagnostics 2010; 10(7): 883 doi: 10.1586/erm.10.76
|
| 65 |
Takayuki Yamaguchi, Yukihiro Yokoyama, Tomoki Ebata, Atsushi Matsuda, Atsushi Kuno, Yuzuru Ikehara, Junichi Shoda, Hisashi Narimatsu, Masato Nagino. Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer. Annals of Surgical Oncology 2016; 23(2): 671 doi: 10.1245/s10434-015-4878-4
|
| 66 |
Xiao-Fang Liu, Kun Tang, Lu-Lu Sui, Gang Xu. Cholangiocarcinoma: Present Status and Molecular Aspects of Diagnosis. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2015; 22(4): 177 doi: 10.3727/096504015X14343704124386
|
| 67 |
Rucksak Rucksaken, Lakhanawan Charoensuk, Porntip Pinlaor, Chawalit Pairojkul, Narong Khuntikeo, Somchai Pinlaor. Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma. Cancer Biomarkers 2017; 18(1): 27 doi: 10.3233/CBM-160670
|
| 68 |
Hong Jin Yoon, Sung Ill Jang, Dong Ki Lee. Advanced ERCP for Complicated and Refractory Biliary and Pancreatic Diseases. 2020; : 127 doi: 10.1007/978-981-13-0608-2_9
|
| 69 |
Azza Mahmoud El Sheashaey, Marium Nagah Al Zafrany Al Agha, Amr ragab Ibrahim shalaby, Salah Mohammed El Kousy, Gamalate Abd Ellatef Elgedawy. Studying of serum bile acids metabolomics as potential biomarkers for differentiation between hepatocellular carcinoma and cholangiocarcinoma. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00376-x
|
| 70 |
Amir A. Rahnemai-Azar, Allison Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis. Surgical Oncology 2017; 26(2): 125 doi: 10.1016/j.suronc.2016.12.009
|
| 71 |
Masakazu Yamamoto, Shun-ichi Ariizumi. Intrahepatic recurrence after surgery in patients with intrahepatic cholangiocarcinoma. Journal of Gastroenterology 2006; 41(9): 925 doi: 10.1007/s00535-006-1901-3
|
| 72 |
Olivier Baton, Daniel Azoulay, Delvart V. René Adam, Denis Castaing. Major Hepatectomy for Hilar Cholangiocarcinoma Type 3 and 4: Prognostic Factors and Longterm Outcomes. Journal of the American College of Surgeons 2007; 204(2): 250 doi: 10.1016/j.jamcollsurg.2006.10.028
|
| 73 |
M. Grunnet, M. Mau-Sørensen. Serum tumor markers in bile duct cancer – a review. Biomarkers 2014; 19(6): 437 doi: 10.3109/1354750X.2014.923048
|
| 74 |
Apa Juntavee, Banchob Sripa, Ake Pugkhem, Narong Khuntikeo, Sopit Wongkham. Expression of sialyl Lewis<sup>a</sup> relates to poor prognosis in cholangiocarcinoma. World Journal of Gastroenterology 2005; 11(2): 249-254 doi: 10.3748/wjg.v11.i2.249
|
| 75 |
Weizeng Ni, Samuel H. Huang, Qiang Su, Jinghua Shi. Model‐Independent Evaluation of Tumor Markers and a Logistic‐Tree Approach to Diagnostic Decision Support. Journal of Healthcare Engineering 2014; 5(4): 393 doi: 10.1260/2040-2295.5.4.393
|
| 76 |
Perihan El Sayed Salem, Rasha Abdelmawla Ghazala, Ahmed Mohamed El Gendi, Doaa Mokhtar Emara, Nesma Mahmoud Ahmed. The association between circulating MicroRNA‐150 level and cholangiocarcinoma. Journal of Clinical Laboratory Analysis 2020; 34(11) doi: 10.1002/jcla.23397
|
| 77 |
Michela Squadroni, Luca Tondulli, Gemma Gatta, Stefania Mosconi, Giordano Beretta, Roberto Labianca. Cholangiocarcinoma. Critical Reviews in Oncology/Hematology 2017; 116: 11 doi: 10.1016/j.critrevonc.2016.11.012
|
| 78 |
Sven H. Loosen, Georg Lurje, Georg Wiltberger, Mihael Vucur, Alexander Koch, Jakob N. Kather, Pia Paffenholz, Frank Tacke, Florian T. Ulmer, Christian Trautwein, Tom Luedde, Ulf P. Neumann, Christoph Roderburg, Niklas K. Björkström. Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma. PLOS ONE 2019; 14(1): e0210944 doi: 10.1371/journal.pone.0210944
|
| 79 |
Jae Hyun Kim, Jeong Hee Yoon, Ijin Joo, Jeong Min Lee. Evaluation of Primary Liver Cancers Using Hepatocyte‐Specific Contrast‐Enhanced MRI: Pitfalls and Potential Tips. Journal of Magnetic Resonance Imaging 2021; 53(3): 655 doi: 10.1002/jmri.27213
|
| 80 |
M. Ventrucci, P. Pozzato, A. Cipolla, G. Uomo. Persistent elevation of serum CA 19-9 with no evidence of malignant disease. Digestive and Liver Disease 2009; 41(5): 357 doi: 10.1016/j.dld.2008.04.002
|
| 81 |
Ke Zhu, Jin Yang, Ying-zhen Chen, Xue-rong Zhang, Xian-huan Yu, Jie Wang, Rui Zhang, Chao Liu. Differences in Clinical Features and Diagnostic Strategies Between IgG4-Related Autoimmune Cholangitis and Cholangiocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.540904
|
| 82 |
Mehrdad Moghimi, Iraj Ghodosi .. Clinical Efficacy of Combined Use of CEA-CA19-9 in Patients with Pancreatic Malignancy. Journal of Medical Sciences 2007; 7(4): 625 doi: 10.3923/jms.2007.625.629
|
| 83 |
Ji Young Park, Tae Joo Jeon. Factors Associated with Malignant Biliary Strictures in Patients with Atypical or Suspicious Cells on Brush Cytology. Clinical Endoscopy 2019; 52(2): 168 doi: 10.5946/ce.2018.105
|
| 84 |
Chun‐Fu Ting, Wen‐Hsin Huang, Chun‐Lung Feng, Cheng‐Ju Yu, Cheng‐Yuan Peng, Wen‐Pang Su, Hsueh‐Chou Lai, Ken‐Sheng Cheng, Po‐Heng Chuang, Jung‐Ta Kao. Clinical factors associated with the survival of patients with intrahepatic cholangiocarcinoma. Advances in Digestive Medicine 2016; 3(1): 11 doi: 10.1016/j.aidm.2014.12.004
|
| 85 |
Anahita Sadeghi, Mehdi Mohamadnejad, Farhad Islami, Abbas Keshtkar, Mohammad Biglari, Reza Malekzadeh, Mohamad A. Eloubeidi. Diagnostic yield of EUS-guided FNA for malignant biliary stricture: a systematic review and meta-analysis. Gastrointestinal Endoscopy 2016; 83(2): 290 doi: 10.1016/j.gie.2015.09.024
|
| 86 |
Laura Izquierdo-Sanchez, Angela Lamarca, Adelaida La Casta, Stefan Buettner, Kirsten Utpatel, Heinz-Josef Klümpen, Jorge Adeva, Arndt Vogel, Ana Lleo, Luca Fabris, Mariano Ponz-Sarvise, Raffaele Brustia, Vincenzo Cardinale, Chiara Braconi, Gianpaolo Vidili, Nigel B. Jamieson, Rocio IR. Macias, Jan Philipp Jonas, Marco Marzioni, Wacław Hołówko, Trine Folseraas, Juozas Kupčinskas, Zeno Sparchez, Marcin Krawczyk, Łukasz Krupa, Viorel Scripcariu, Gian Luca Grazi, Ana Landa-Magdalena, Jan NM. Ijzermans, Katja Evert, Joris I. Erdmann, Flora López-López, Anna Saborowski, Alexander Scheiter, Alvaro Santos-Laso, Guido Carpino, Jesper B. Andersen, Jose JG. Marin, Domenico Alvaro, Luis Bujanda, Alejandro Forner, Juan W. Valle, Bas Groot Koerkamp, Jesus M. Banales. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry. Journal of Hepatology 2022; 76(5): 1109 doi: 10.1016/j.jhep.2021.12.010
|
| 87 |
Waraporn Saentaweesuk, Atit Silsirivanit, Kulthida Vaeteewoottacharn, Kanlayanee Sawanyawisuth, Chawalit Pairojkul, Ubon Cha'on, Somsiri Indramanee, Somchai Pinlaor, Thidarut Boonmars, Norie Araki, Chaisiri Wongkham. Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis. Clinica Chimica Acta 2018; 477: 66 doi: 10.1016/j.cca.2017.12.005
|
| 88 |
Ramakrishnan Arulraj, James Neuberger. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. 2012; : 1662 doi: 10.1016/B978-1-4377-1454-8.00097-7
|
| 89 |
Akinobu Taketomi, Yoshihiko Maehara. Patient Surveillance After Cancer Treatment. 2013; : 165 doi: 10.1007/978-1-60327-969-7_30
|
| 90 |
Jinjin Cao, Shravya Srinivas-Rao, Nayla Mroueh, Roshni Anand, Sasiprang Kongboonvijit, Madeleine Sertic, Anuradha S. Shenoy-Bhangle, Avinash Kambadakone. Cholangiocarcinoma imaging: from diagnosis to response assessment. Abdominal Radiology 2024; 49(5): 1699 doi: 10.1007/s00261-024-04267-y
|
| 91 |
Hyeong Seok Kim, Youngmin Han, Jae Seung Kang, Yoon Hyung Kang, Mirang Lee, Hee Ju Sohn, Hongbeom Kim, Wooil Kwon, Jin-Young Jang. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 as preoperative diagnostic biomarkers of extrahepatic bile duct cancer. BJS Open 2021; 5(6) doi: 10.1093/bjsopen/zrab127
|
| 92 |
Yun HUANG, Yu XU, Yufang BI, Min XU, Jieli LU, Tiange WANG, Mian LI, Yuhong CHEN, Yu LIU, Fei HUANG, Baihui XU, Jie ZHANG, Weiqing WANG, Guang NING. Relationship between CA 19‐9 levels and glucose regulation in a middle‐aged and elderly Chinese population. Journal of Diabetes 2012; 4(2): 147 doi: 10.1111/j.1753-0407.2011.00179.x
|
| 93 |
Stefania Mosconi, Giordano D. Beretta, Roberto Labianca, Maria G. Zampino, Gemma Gatta, Volker Heinemann. Cholangiocarcinoma. Critical Reviews in Oncology/Hematology 2009; 69(3): 259 doi: 10.1016/j.critrevonc.2008.09.008
|
| 94 |
Kook Hyun Kim. Diagnostic Approach to Indeterminate Biliary Stricture. The Korean Journal of Pancreas and Biliary Tract 2018; 23(3): 101 doi: 10.15279/kpba.2018.23.3.101
|
| 95 |
Yuki Tanisaka, Masafumi Mizuide, Akashi Fujita, Tomoya Ogawa, Hiromune Katsuda, Youichi Saito, Kazuya Miyaguchi, Ryuhei Jinushi, Rie Terada, Yuya Nakano, Tomoaki Tashima, Yumi Mashimo, Shomei Ryozawa. Current Status of Endoscopic Biliary Drainage in Patients with Distal Malignant Biliary Obstruction. Journal of Clinical Medicine 2021; 10(19): 4619 doi: 10.3390/jcm10194619
|
| 96 |
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, Taku Yamashita, Koji Araki, Kohei Horimoto, Satoshi Yajima, Masakazu Yashiro, Keigo Yokoi, Haruhiko Cho, Takuya Ehira, Kazunari Nakahara, Hiroshi Yasuda, Kazutoshi Isobe, Tetsu Hayashida, Shingo Hatakeyama, Koichiro Akakura, Daisuke Aoki, Hiroyuki Nomura, Yuji Tada, Yuki Yoshimatsu, Hayato Miyachi, Chiaki Takebayashi, Ichiro Hanamura, Hiroyuki Takahashi. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2. International Journal of Clinical Oncology 2024; 29(5): 512 doi: 10.1007/s10147-024-02497-0
|
| 97 |
L Yang, S Feng, Y Yang. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis. Cancer Gene Therapy 2016; 23(12): 439 doi: 10.1038/cgt.2016.64
|
| 98 |
Cherif Boutros, Ponnandai Somasundar, N. Joseph Espat. Extrahepatic Cholangiocarcinoma: Current Surgical Strategy. Surgical Oncology Clinics of North America 2009; 18(2): 269 doi: 10.1016/j.soc.2008.12.003
|
| 99 |
Amrita Sethi, Douglas A. Howell. Clinical Gastrointestinal Endoscopy. 2019; : 699 doi: 10.1016/B978-0-323-41509-5.00060-8
|
| 100 |
Giulia Malaguarnera, Maria Giordano, Isabella Paladina, Alessandra Rando, Mario Uccello, Francesco Basile, Antonio Biondi, Santo Carnazzo, Innocenza Alessandria, Clorinda Mazzarino. Markers of bile duct tumors. World Journal of Gastrointestinal Oncology 2011; 3(4): 49-59 doi: 10.4251/wjgo.v3.i4.49
|
| 101 |
Margaret Wheless, Rajiv Agarwal, Laura Goff, Natalie Lockney, Chandrasekhar Padmanabhan, Thatcher Heumann. Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma. Current Treatment Options in Oncology 2024; 25(1): 127 doi: 10.1007/s11864-023-01153-5
|
| 102 |
Siddinath Gyawali, Biraj Pokhrel, Pratik Uprety, Arun Gnawali. IgG4‐related sclerosing cholangitis, a mimicker of the cholangiocarcinoma: A case report. Clinical Case Reports 2023; 11(2) doi: 10.1002/ccr3.6935
|
| 103 |
Rucksak Rucksaken, Chawalit Pairojkul, Porntip Pinlaor, Narong Khuntikeo, Sittiruk Roytrakul, Carlo Selmi, Somchai Pinlaor, Gabriele Multhoff. Plasma Autoantibodies against Heat Shock Protein 70, Enolase 1 and Ribonuclease/Angiogenin Inhibitor 1 as Potential Biomarkers for Cholangiocarcinoma. PLoS ONE 2014; 9(7): e103259 doi: 10.1371/journal.pone.0103259
|
| 104 |
Clotilde Della Pina, Erika Rocchi, Andrea Conti, Sara Montagnani, Laura Crocetti. Focal Liver Lesions. Medical Radiology 2005; : 203 doi: 10.1007/3-540-26354-3_14
|
| 105 |
He Wen, Sung Soo Yoo, Jinho Kang, Hee Goo Kim, Jin-Seok Park, Seok Jeong, Jung Il Lee, Hyuk Nam Kwon, Sunmi Kang, Don-Haeng Lee, Sunghyouk Park. A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. Journal of Hepatology 2010; 52(2): 228 doi: 10.1016/j.jhep.2009.11.002
|
| 106 |
Satoru Suzuki, Jun-ichirou Mori, Masanori Yamazaki, Ai Sato, Waki Hosoda, Kiyoshi Hashizume. Beneficial Effects of Pioglitazone on Cholangiohepatitis Induced by Bile Duct Carcinoma. Internal Medicine 2007; 46(20): 1723 doi: 10.2169/internalmedicine.46.0312
|
| 107 |
Lisa Heinrichs, Georg Fluegen, Sven H. Loosen, Christina Loberg, Linda Wittig, Alexander Quaas, Patrick S. Plum, Nils Große Hokamp, Peter Minko, Andreas Krieg, Gerald Antoch, Wolfram T. Knoefel, Tom Luedde, Christoph Roderburg, Markus S. Jördens. Bone mineral density as a prognostic marker in patients with biliary tract cancer undergoing surgery. BJC Reports 2024; 2(1) doi: 10.1038/s44276-024-00094-2
|
| 108 |
Rossana Berardi, Federico Mocchegiani, Chiara Pierantoni, Alen Federici, Daniele Nicolini, Francesca Morgese, Azzurra Onofri, Andrea Risaliti, Marco Vivarelli, Stefano Cascinu. Resected biliary tract cancers: A novel clinical–pathological score correlates with global outcome. Digestive and Liver Disease 2013; 45(1): 70 doi: 10.1016/j.dld.2012.08.012
|
| 109 |
Anastasios Gkountakos, Filippo M. Martelli, Nicola Silvestris, Michele Bevere, Mario De Bellis, Laura Alaimo, Elena Sapuppo, Francesca Masetto, Aldo Mombello, Michele Simbolo, Elena Bariani, Michele Milella, Matteo Fassan, Aldo Scarpa, Claudio Luchini. Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment. Cancers 2023; 15(5): 1454 doi: 10.3390/cancers15051454
|
| 110 |
Hiroaki Okuda, Keiko Shiratori, Masakazu Yamamoto, Ken Takasaki, Masayuki Nakano. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for α‐fetoprotein‐L3 and those with combined hepatocellular and cholangiocarcinoma. Journal of Gastroenterology and Hepatology 2006; 21(5): 869 doi: 10.1111/j.1440-1746.2006.04257.x
|
| 111 |
Ivan Isaia, Giuseppe Natoli, Michele Colaci, Benedetta Stancanelli, Lorenzo Malatino. Sclerosing cholangitis may mimic radiological pattern of cholangiocarcinoma: Differential diagnosis and review of literature. The American Journal of the Medical Sciences 2022; 364(3): 359 doi: 10.1016/j.amjms.2022.04.016
|
| 112 |
Sirorat Pattanapairoj, Atit Silsirivanit, Kanha Muisuk, Wunchana Seubwai, Ubon Cha'on, Kulthida Vaeteewoottacharn, Kanlayanee Sawanyawisuth, Danaipong Chetchotsak, Sopit Wongkham. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach. Clinical Biochemistry 2015; 48(10-11): 668 doi: 10.1016/j.clinbiochem.2015.03.022
|
| 113 |
Hai-Jie Hu, Hui Mao, Yong-Qiong Tan, Anuj Shrestha, Wen-Jie Ma, Qin Yang, Jun-Ke Wang, Nan-Sheng Cheng, Fu-Yu Li. Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-2181-x
|
| 114 |
Jisce R Puik, Laura L Meijer, Tessa YS Le Large, Mireia Mato Prado, Adam E Frampton, Geert Kazemier, Elisa Giovannetti. miRNA Profiling for Diagnosis, Prognosis and Stratification of Cancer Treatment in Cholangiocarcinoma. Pharmacogenomics 2017; 18(14): 1343 doi: 10.2217/pgs-2017-0010
|
| 115 |
Soo Young Jang, Jin Sil Kim, Seung Yon Baek, Hye Ah Lee, Jeong Kyong Lee. Proposed nomogram predicting neoplastic ampullary obstruction in patients with a suspected ampulla of Vater lesion on CT. Abdominal Radiology 2021; 46(7): 3128 doi: 10.1007/s00261-021-02975-3
|
| 116 |
Liqiang Qian, Gang Wang, Bin Li, Haoyuan Su, Lei Qin. Regulation of lipid metabolism by APOE4 in intrahepatic cholangiocarcinoma via the enhancement of ABCA1 membrane expression. PeerJ 2024; 12: e16740 doi: 10.7717/peerj.16740
|
| 117 |
Mrinalini Meesala, Muhammad Raza, Avneesh Chhabra, Nilay Mehta, Diwakar Jain. Hepatobiliary abnormalities on nuclear perfusion imaging. Journal of Nuclear Cardiology 2006; 13(2): 297 doi: 10.1016/j.nuclcard.2006.01.008
|
| 118 |
T. Clark Gamblin, A.M. Krasinskas, A.S. Slivka, M.E. Tublin, Jake Demetris, Eveline Shue, Susan Caro, J. Wallis Marsh, A. James Moser. Fibroinflammatory Biliary Stricture: A Rare Bile Duct Lesion Masquerading as Cholangiocarcinoma. Journal of Gastrointestinal Surgery 2009; 13(4): 713 doi: 10.1007/s11605-008-0750-1
|